Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study

Mulhall BP, 2002, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol, 17, 1136

10.1016/S0016-5085(99)70506-8

10.1161/01.CIR.0000088845.17586.EC

Marchesini G, 1999, Association of non-alcoholic fatty liver disease to insulin resistance. Am J Med, 107, 450

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2001, Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. J Am Med Assoc, 285, 2486

10.1161/01.ATV.0000160613.57985.18

10.1016/j.metabol.2005.03.010

Saverymuttu SH, 1986, Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed), 292, 13, 10.1136/bmj.292.6512.13

10.1053/gast.2002.35354

10.1097/01.mol.0000174153.53683.f2

Adams LA, 2004, Indian J Gastroenterol, 23, 127

10.1172/JCI23621

10.1016/S0168-8278(97)80287-5

Dixon JB, 2004, Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology, 39, 1647

10.1136/gut.2003.027581

10.1185/030079904125004466

Hatzitolios A, 2004, Indian J Gastroenterol, 23, 131

10.1111/j.1365-2036.2004.02153.x

10.1111/j.1365-2036.2004.01888.x

10.1111/j.1572-0241.2005.41583.x

10.1002/hep.20012

10.1136/gut.2003.027086

10.1002/hep.20420

Kiyici M, 2003, Can J Gastroenterol, 17, 713, 10.1155/2003/857869

10.1016/S1388-1981(01)00201-3

10.1016/S0021-9150(00)00407-X

10.1007/s11883-001-0015-x

10.1016/S0021-9150(02)00117-X

Athyros VG, 2004, Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease. A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Am J Kidney Dis, 43, 589

10.1097/00005344-199907000-00010

10.1093/aje/kwg260

10.2337/diabetes.52.11.2840

Lonardo A, 2002, ST.E.N.A. Study Group. Policentrica Steatosi Epatica Non Alcolica. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis, 34, 204

10.1210/jcem.86.9.7873

10.1111/j.1440-1746.2004.03362.x

Kerner A, 2005, Arterioscler Thromb Vasc Biol, 25, 193, 10.1161/01.ATV.0000148324.63685.6a

10.1097/00041433-200412000-00005

Athyros VG, 2004, for the METS-Greece Collaborative Group. Prevalence of atherosclerotic cardiovascular disease among subjects with the metabolic syndrome with or without diabetes mellitus. Curr Med Res Opin, 20, 1691

10.1194/jlr.M300309-JLR200

Rallidis LS, 2004, Parasi AS. Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study. Atherosclerosis, 174, 193

10.1161/01.CIR.0000080895.05158.8B

10.1016/j.freeradbiomed.2004.06.033

10.1136/gut.2003.037309

10.1053/jhep.2003.50161

10.1053/j.gastro.2004.02.015

10.1046/j.1472-8206.2003.00176.x

10.1016/j.jhep.2004.07.010

10.1002/hep.20466

10.1111/j.1464-5491.2005.01582.x

Franzese A, 1997, Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci, 42, 1428

10.1007/BF02208670

Targher G, 2005, Role of visceral adipose tissue. Diabetic Med, 22, 1354

10.1016/j.jhep.2005.06.008

10.7326/0003-4819-143-10-200511150-00009

Liberopoulos EN, 2005, Diagnosis and management of the metabolic syndrome in obesity. Obes Rev, 6, 283

10.2337/diabetes.54.12.3541